These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 14517714)

  • 1. Polymorphisms in the CYP19 and AR genes--relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy: The Danish Osteoporosis Prevention Study.
    Tofteng CL; Kindmark A; Brändström H; Abrahamsen B; Petersen S; Stiger F; Stilgren LS; Jensen JE; Vestergaard P; Langdahl BL; Mosekilde L;
    Calcif Tissue Int; 2004 Jan; 74(1):25-34. PubMed ID: 14517714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of androgen receptor gene polymorphism to bone mineral density and fracture risk in early postmenopausal women during a 5-year randomized hormone replacement therapy trial.
    Salmén T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Pallonen H; Saarikoski S; Honkanen R; Mäenpää PH
    J Bone Miner Res; 2003 Feb; 18(2):319-24. PubMed ID: 12568409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two polymorphisms in the vitamin D receptor gene--association with bone mass and 5-year change in bone mass with or without hormone-replacement therapy in postmenopausal women: the Danish Osteoporosis Prevention Study.
    Tofteng CL; Jensen JE; Abrahamsen B; Odum L; Brot C
    J Bone Miner Res; 2002 Aug; 17(8):1535-44. PubMed ID: 12162507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between androgen receptor gene polymorphism and bone density in older women using hormone replacement therapy.
    Retornaz F; Paris F; Lumbroso S; Audran F; Tigoulet F; Michelon C; Jeandel C; Sultan C; Blain H
    Maturitas; 2006 Nov; 55(4):325-33. PubMed ID: 16759824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A CAG repeat polymorphism in the androgen receptor gene is associated with reduced bone mass and increased risk of osteoporotic fractures.
    Langdahl BL; Stenkjaer L; Carstens M; Tofteng CL; Eriksen EF
    Calcif Tissue Int; 2003 Sep; 73(3):237-43. PubMed ID: 14667136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish osteoporosis prevention study.
    Abrahamsen B; Madsen JS; Tofteng CL; Stilgren L; Bladbjerg EM; Kristensen SR; Brixen K; Mosekilde L
    J Bone Miner Res; 2003 Apr; 18(4):723-9. PubMed ID: 12674333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COL1A1 Sp1 polymorphism predicts perimenopausal and early postmenopausal spinal bone loss.
    MacDonald HM; McGuigan FA; New SA; Campbell MK; Golden MH; Ralston SH; Reid DM
    J Bone Miner Res; 2001 Sep; 16(9):1634-41. PubMed ID: 11547832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of an aromatase TTTA repeat polymorphism with circulating estrogen, bone structure, and biochemistry in older women.
    Dick IM; Devine A; Prince RL
    Am J Physiol Endocrinol Metab; 2005 May; 288(5):E989-95. PubMed ID: 15613678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aromatase gene and osteoporosis: relationship of ten polymorphic loci with bone mineral density.
    Riancho JA; Zarrabeitia MT; Valero C; Sañudo C; Hernández JL; Amado JA; Zarrabeitia A; González-Macías J
    Bone; 2005 May; 36(5):917-25. PubMed ID: 15794932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of sex hormone-binding globulin and androgen receptor gene variants in the development of polycystic ovary syndrome.
    Xita N; Georgiou I; Lazaros L; Psofaki V; Kolios G; Tsatsoulis A
    Hum Reprod; 2008 Mar; 23(3):693-8. PubMed ID: 18192296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor alpha gene polymorphisms and bone mineral density: haplotype analysis in women from the United Kingdom.
    Albagha OM; McGuigan FE; Reid DM; Ralston SH
    J Bone Miner Res; 2001 Jan; 16(1):128-34. PubMed ID: 11149476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor alpha gene polymorphisms are associated with changes in bone remodeling markers and treatment response to estrogen.
    Rapuri PB; Gallagher JC; Knezetic JA; Haynatzka V
    Maturitas; 2006 Mar; 53(4):371-9. PubMed ID: 16139450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related influence of common aromatase gene polymorphisms on bone mass of healthy men.
    Zarrabeitia A; Zarrabeitia MT; Valero C; González-Macías J; Riancho JA
    Bone; 2004 Jul; 35(1):243-8. PubMed ID: 15207764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: effect of hormone replacement therapy.
    Salmén T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Saarikoski S; Honkanen R; Mäenpää PH
    J Bone Miner Res; 2000 Feb; 15(2):315-21. PubMed ID: 10703934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between endogenous estrogen, sex hormone-binding globulin, and bone loss in female residents of a rural Japanese community: the Taiji Study.
    Yoshimura N; Kasamatsu T; Sakata K; Hashimoto T; Cooper C
    J Bone Miner Metab; 2002; 20(5):303-10. PubMed ID: 12203037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between polymorphisms in tumor necrosis factor (TNF) and TNF receptor genes and circulating TNF, soluble TNF receptor levels, and bone mineral density in postmenopausal Korean women.
    Kim H; Chun S; Ku SY; Suh CS; Choi YM; Kim JG
    Menopause; 2009; 16(5):1014-20. PubMed ID: 19369902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of bone mineral density from vitamin D receptor polymorphisms is uncertain in representative samples of Japanese Women. The Japanese Population-based Osteoporosis (JPOS) Study.
    Morita A; Iki M; Dohi Y; Ikeda Y; Kagamimori S; Kagawa Y; Matsuzaki T; Yoneshima H; Marumo F;
    Int J Epidemiol; 2004 Oct; 33(5):979-88. PubMed ID: 15358739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordance between changes in bone mineral density measured at different skeletal sites in perimenopausal women--implications for assessment of bone loss and response to therapy: The Danish Osteoporosis Prevention Study.
    Abrahamsen B; Stilgren LS; Hermann AP; Tofteng CL; Bärenholdt O; Vestergaard P; Brot C; Nielsen SP
    J Bone Miner Res; 2001 Jul; 16(7):1212-9. PubMed ID: 11450696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailable estradiol and an aromatase gene polymorphism are determinants of bone mineral density changes in men over 70 years of age.
    Van Pottelbergh I; Goemaere S; Kaufman JM
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3075-81. PubMed ID: 12843146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.